Luc Buée

Active 1991–2026

Also published as
Luc Buee
184
Papers
26,012
Citations
89
h-index
172
i10-index

Citations

Citations per year for Luc Buée1949: 1 citations1991: 2 citations1992: 1 citations1993: 2 citations1994: 13 citations1995: 11 citations1996: 20 citations1997: 77 citations1998: 92 citations1999: 102 citations2000: 108 citations2001: 121 citations2002: 147 citations2003: 116 citations2004: 159 citations2005: 119 citations2006: 121 citations2007: 120 citations2008: 135 citations2009: 143 citations2010: 189 citations2011: 193 citations2012: 216 citations2013: 176 citations2014: 291 citations2015: 231 citations2016: 352 citations2017: 307 citations2018: 343 citations2019: 1,088 citations2020: 1,298 citations2021: 1,389 citations2022: 1,187 citations2023: 978 citations2024: 1,234 citations2025: 686 citations2026: 21 citations1950–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,645 citing papers, 25.7% of this breakdownChina: 1,491 citing papers, 10.5% of this breakdownUnited Kingdom: 942 citing papers, 6.6% of this breakdownFrance: 762 citing papers, 5.4% of this breakdownGermany: 737 citing papers, 5.2% of this breakdownCanada: 503 citing papers, 3.6% of this breakdownItaly: 497 citing papers, 3.5% of this breakdownSpain: 461 citing papers, 3.3% of this breakdownAustralia: 394 citing papers, 2.8% of this breakdownJapan: 383 citing papers, 2.7% of this breakdownIndia: 377 citing papers, 2.7% of this breakdownSweden: 316 citing papers, 2.2% of this breakdown
0%25.7%Other 25.8%

Fields

  • Medicine55.3%
  • Biochemistry, Genetics and Molecular Biology22.6%
  • Neuroscience17.1%
  • Immunology and Microbiology1.3%
  • Computer Science0.5%
  • Engineering0.5%
  • Other2.7%

Topics

  • Alzheimer's disease research and treatments18.5%
  • Neuroinflammation and Neurodegeneration Mechanisms6.5%
  • Dementia and Cognitive Impairment Research3.4%
  • Cholinesterase and Neurodegenerative Diseases3.4%
  • Neuroscience and Neuropharmacology Research3%
  • Tryptophan and brain disorders2.6%
  • Other62.6%

Coauthors

All papers

Open in search
  1. NLRP3 inflammasome activation drives tau pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 1,559

  2. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

    Authors: , , , , - Brain Research Reviews 2000 cited by 1,996

  3. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies

    Authors: , , , , , , , , , , , - Biomolecules 2016 cited by 713

  4. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains

    Authors: , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2020 cited by 253

  5. Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology

    Authors: , , , , , , , , , , - EMBO Molecular Medicine 2020 cited by 298

  6. IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , - Cell Reports 2021 cited by 210

  7. What is the evidence that tau pathology spreads through prion-like propagation?

    Authors: , , , , , , , , , , - Acta Neuropathologica Communications 2017 cited by 374

  8. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy

    Authors: , , , , , , , , , , , , , , , , , , , , - Brain 2016 cited by 288

  9. Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2020 cited by 227

  10. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?

    Authors: , , - Biomedical Journal 2018 cited by 345

  11. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody

    Authors: , , , , , , , , , , , , , , - Brain 2019 cited by 184

  12. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies

    Authors: , , , , , , , - Acta Neuropathologica Communications 2016 cited by 297

  13. A walk through tau therapeutic strategies

    Authors: , , , , , , , , , , , - Acta Neuropathologica Communications 2019 cited by 289

  14. PART is part of Alzheimer disease

    Authors: , , , , , , , , , , - Acta Neuropathologica 2015 cited by 325

  15. Monoaminergic neuropathology in Alzheimer’s disease

    Authors: , , , , , , , , , , , - Progress in Neurobiology 2016 cited by 293

  16. Tau deletion promotes brain insulin resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2017 cited by 202

  17. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacques Epelbaum, Marc Mercken, Eric Karran, Marcus Bantscheff, Gerard Drewes, Gérard Joberty, Dominique Campion, J-N Octave, Claudine Berr, Mark Lathrop, Patrick Callaerts, David M. A. Mann, Julie Williams, Luc Buée, Ilse Dewachter, Christine Van Broeckhoven, Philippe Amouyel, Dieder Moechars, Bart Dermaut, J-C Lambert - Molecular Psychiatry 2013 cited by 440

  18. Nuclear Tau, a Key Player in Neuronal DNA Protection

    Authors: , , , , , , , , , , , , , - Journal of Biological Chemistry 2010 cited by 405

  19. Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits

    Authors: , , , , , , - American Journal Of Pathology 2006 cited by 383

  20. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregationin vivo

    Authors: , , , , , , , , , , , , , , , , - Human Molecular Genetics 2015 cited by 237

  21. GnRH replacement rescues cognition in Down syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nasser Haddjeri, Anne‐Laurence Boutillier, Jens Kühle, Andrea Messina, Bogdan Draganski, Paolo Giacobini, Nelly Pitteloud, Vincent Prévot - Science 2022 cited by 89

  22. Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2018 cited by 180

  23. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

    Authors: , , , , , , , , , , , , , , , , - Nature 1996 cited by 1,453

  24. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment

    Authors: , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2024 cited by 50